SCHEMBL9563510

SCHEMBL9563510

Cc1ccc(N)c(C(=O)c2ccc[nH]2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
NPC1 O15118 2/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
L3MBTL1 Q9Y468 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.43
KDM4E B2RXH2 4/20 0.43
RAB9A P51151 1/20 0.43
FGFR1 P11362 1/20 0.42
FGFR2 P21802 1/20 0.42
FGFR3 P22607 1/20 0.42
CYP1A2 P05177 1/20 0.42
ALOX15 P16050 2/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9686196 0.81 MAPT (0.61) MAPTNPC1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL9563508 0.81 KEAP1 (0.54) MAPTMAPK1HTTL3MBTL1SMN1; SMN2
Acetic Acid SCHEMBL6271336 0.78 L3MBTL1 (0.47) MAPTNPC1HTTL3MBTL1SMN1; SMN2
SCHEMBL9563516 0.77 SMN1; SMN2 (0.74) MAPTNPC1HTTL3MBTL1SMN1; SMN2
SCHEMBL5383825 0.76 MAPT (0.73) MAPTNPC1MAPK1HTTL3MBTL1
SCHEMBL31366618 0.76 MAPT (0.73) MAPTNPC1MAPK1HTTL3MBTL1
SCHEMBL2353757 0.75 ALDH1A1 (0.58) NPC1L3MBTL1SMN1; SMN2KDM4ERAB9A
SCHEMBL9650611 0.73 PARP1 (0.50) MAPTL3MBTL1SMN1; SMN2KDM4EPOLB
SCHEMBL4683307 0.73 ALDH1A1 (0.50) NPC1L3MBTL1SMN1; SMN2KDM4ERAB9A
SCHEMBL13328057 0.73 TPMT (0.47) MAPTNPC1L3MBTL1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0552665-A1 Pyrrolylbenzodiazepinones and medicines containing them F. HOFFMANN-LA ROCHE AG (CH) 1993-07-28 EP disclosed